Estimating misclassification error in a binary performance indicator: case study of low value care in Australian hospitals.

health services research healthcare quality improvement performance measures quality measurement

Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
12 2020
Historique:
received: 30 10 2019
revised: 17 02 2020
accepted: 23 02 2020
pubmed: 14 3 2020
medline: 16 9 2021
entrez: 14 3 2020
Statut: ppublish

Résumé

Indicators based on hospital administrative data have potential for misclassification error, especially if they rely on clinical detail that may not be well recorded in the data. We applied an approach using modified logistic regression models to assess the misclassification (false-positive and false-negative) rates of low-value care indicators. We applied indicators involving 19 procedures to an extract from the New South Wales Admitted Patient Data Collection (1 January 2012 to 30 June 2015) to label episodes as low value. We fit four models (no misclassification, false-positive only, false-negative only, both false-positive and false-negative) for each indicator to estimate misclassification rates and used the posterior probabilities of the models to assess which model fit best. False-positive rates were low for most indicators-if the indicator labels care as low value, the care is most likely truly low value according to the relevant recommendation. False-negative rates were much higher but were poorly estimated (wide credible intervals). For most indicators, the models allowing no misclassification or allowing false-negatives but no false-positives had the highest posterior probability. The overall low-value care rate from the indicators was 12%. After adjusting for the estimated misclassification rates from the highest probability models, this increased to 35%. Binary performance indicators have a potential for misclassification error, especially if they depend on clinical information extracted from administrative data. Indicators should be validated by chart review, but this is resource-intensive and costly. The modelling approach presented here can be used as an initial validation step to identify and revise indicators that may have issues before continuing to a full chart review validation.

Identifiants

pubmed: 32165412
pii: bmjqs-2019-010564
doi: 10.1136/bmjqs-2019-010564
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

992-999

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AGE holds a HCF Research Foundation Professorial Research Fellowship, and receives income as a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce, a member of the Choosing Wisely Australia advisory group, the Choosing Wisely International Planning Committee, the ACSQHC’s Atlas of Healthcare Variation Advisory Group, a Board Member of the NSW Bureau of Health Information (BHI), and as a consultant to Private Healthcare Australia and the Queensland and Victoria state health departments. TB-P has received scholarship income from the University of Sydney and the Capital Markets Cooperative Research Centre, and consulting fees from the Capital Markets Cooperative Research Centre, Queensland Health, the Victorian Department of Health and Human Services, and Private Healthcare Australia.

Auteurs

Tim Badgery-Parker (T)

Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia tim.badgeryparker@sydney.edu.au.

Sallie-Anne Pearson (SA)

Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Adam G Elshaug (AG)

Faculty of Medicine and Health, School of Public Health, Menzies Centre for Health Policy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
The Brookings Institution, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH